|
1
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jia Y, Wang N, Wang J, Tian H, Ma W, Wang
K, Tan B, Zhang G, Yang S, Bai B and Cheng Y: Down-regulation of
stromal caveolin-1 expression in esophageal squamous cell
carcinoma: A potent predictor of lymph node metastases, early tumor
recurrence, and poor prognosis. Ann Surg Oncol. 21:329–336. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang K, Ma W, Wang J, Yu L, Zhang X, Wang
Z, Tan B, Wang N, Bai B, Yang S, et al: Tumor-stroma ratio is an
independent predictor for survival in esophageal squamous cell
carcinoma. J Thorac Oncol. 7:1457–1461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu YH, Liu H, Zhang LY, Zeng T, Song Y,
Qin YR, Li L, Liu L, Li J, Zhang B and Guan XY: Downregulation of
LGI1 promotes tumor metastasis in esophageal squamous cell
carcinoma. Carcinogenesis. 35:1154–1161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xuan X, Li Q, Zhang Z, Du Y and Liu P:
Increased expression levels of S100A4 associated with
hypoxia-induced invasion and metastasis in esophageal squamous cell
cancer. Tumour Biol. 35:12535–12543. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu Y, Correa AM, Hoque A, Guan B, Ye F,
Huang J, Swisher SG, Wu TT, Ajani JA and Xu XC: Prognostic
significance of differentially expressed miRNAs in esophageal
cancer. Int J Cancer. 128:132–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kashyap MK, Harsha HC, Renuse S, Pawar H,
Sahasrabuddhe NA, Kim MS, Marimuthu A, Keerthikumar S, Muthusamy B,
Kandasamy K, et al: SILAC-based quantitative proteomic approach to
identify potential biomarkers from the esophageal squamous cell
carcinoma secretome. Cancer Biol Ther. 10:796–810. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Z, Feng JG, Tuersun A, Liu T, Liu H,
Liu Q, Zheng ST, Huang CG, Lv GD, Sheyhidin I and Lu XM: Proteomic
identification of differentially-expressed proteins in esophageal
cancer in three ethnic groups in Xinjiang. Mol Biol Rep.
38:3261–3269. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Wang K, Zhang J, Liu SS, Dai L
and Zhang JY: Using proteomic approach to identify tumor-associated
proteins as biomarkers in human esophageal squamous cell carcinoma.
J Proteome Res. 10:2863–2872. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ying J, Shan L, Li J, Zhong L, Xue L, Zhao
H, Li L, Langford C, Guo L, Qiu T, et al: Genome-wide screening for
genetic alterations in esophageal cancer by aCGH identifies 11q13
amplification oncogenes associated with nodal metastasis. PLoS one.
7:e397972012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uemura N, Nakanishi Y, Kato H, Saito S,
Nagino M, Hirohashi S and Kondo T: Transglutaminase 3 as a
prognostic biomarker in esophageal cancer revealed by proteomics.
Int J Cancer. 124:2106–2115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Z, Guan B, Men T, Fujimoto J and Xu
X: Comparable molecular alterations in 4-nitroquinoline
1-oxide-induced oral and esophageal cancer in mice and in human
esophageal cancer, associated with poor prognosis of patients. In
vivo. 27:473–484. 2013.PubMed/NCBI
|
|
13
|
Moghanibashi M, Jazii FR, Soheili ZS, Zare
M, Karkhane A, Parivar K and Mohamadynejad P: Proteomics of a new
esophageal cancer cell line established from Persian patient. Gene.
500:124–133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan NJ, Gao CF, Wang CS, Zhao G, Lv JJ,
Wang XL, Chu GH, Yin J, Li DH, Chen X, et al: Identification of the
up-regulation of TP-alpha, collagen alpha-1(VI) chain and S100A9 in
esophageal squamous cell carcinoma by a proteomic method. J
Proteomics. 75:3977–3986. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
da Costa DM, Neves-Filho EH, Alves MK and
Rabenhorst SH: Interleukin polymorphisms and differential
methylation status in gastric cancer: An association with
Helicobacter pylori infection. Epigenomics. 5:167–175. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue H, Lin B, Ni P, Xu H and Huang G:
Interleukin-1B and interleukin-1 RN polymorphisms and gastric
carcinoma risk: A meta-analysis. J Gastroenterol Hepatol.
25:1604–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dabrowska M, Skoneczny M and Rode W:
Functional gene expression profile underlying methotrexate-induced
senescence in human colon cancer cells. Tumor Biol. 32:965–976.
2011. View Article : Google Scholar
|
|
18
|
Su CC, Su JH, Lin JJ, Chen CC, Hwang WI,
Huang HH and Wu YJ: An investigation into the cytotoxic effects of
13-acetoxysarcocrassolide from the soft coral Sarcophyton
crassocaule on bladder cancer cells. Mar Drugs. 9:2622–2642. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong P, He XW, Gu J, Wu WG, Li ML, Yang
JH, Zhang L, Ding QC, Lu JH, Mu JS, et al: Vimentin significantly
promoted gallbladder carcinoma metastasis. Chin Med J (Engl).
124:4236–4244. 2011.PubMed/NCBI
|
|
20
|
Butler MW, Fukui T, Salit J, Shaykhiev R,
Mezey JG, Hackett NR and Crystal RG: Modulation of cystatin A
expression in human airway epithelium related to genotype, smoking,
COPD, and lung cancer. Cancer Res. 71:2572–2581. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lan YJ, Chen H, Chen JQ, Lei QH, Zheng M
and Shao ZR: Immunolocalization of vimentin, keratin 17, Ki-67,
Involucrin, β-catenin and E-cadherin in cutaneous squamous cell
carcinoma. Pathol Oncol Res. 20:263–266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia L, Shen C, Fu Y, Tian L and Chen M:
MGC29506 induces cell cycle arrest and is downregulated in gastric
cancer. Cell Immunol. 281:31–36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen JH, Chen LM, Xu LY, Wu MY and Shen
ZY: Expression and significance of heat shock proteins in
esophageal squamous cell carcinoma. Zhonghua zhong liu za zhi.
28:758–761. 2006.(In Chinese). PubMed/NCBI
|
|
24
|
Choi HS, Yim SH, Xu HD, Jung SH, Shin SH,
Hu HJ, Jung CK, Choi JY and Chung YJ: Tropomyosin3 overexpression
and a potential link to epithelial-mesenchymal transition in human
hepatocellular carcinoma. BMC cancer. 10:1222010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pieples K, Arteaga G, Solaro RJ, Grupp I,
Lorenz JN, Boivin GP, Jagatheesan G, Labitzke E, DeTombe PP,
Konhilas JP, et al: Tropomyosin 3 expression leads to
hypercontractility and attenuates myofilament length-dependent
Ca(2+) activation. Am J Physiol Heart Circ Physio. 283:H1344–H1353.
2002. View Article : Google Scholar
|
|
26
|
Greco A, Miranda C and Pierotti MA:
Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol
Cell Endocrinol. 321:44–49. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Z, Yang R, Zhao J, Yuan R, Lu Q, Li Q
and Tse W: Molecular diagnosis and targeted therapy of a pediatric
chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusion.
Pediatr Blood Cancer. 56:463–466. 2011. View Article : Google Scholar : PubMed/NCBI
|
